Consortium Members

The GUIDE.MRD consortium has 24 members. It is comprised of leading academics, technology companies, pharmaceutical companies, and experts in multi-stakeholder engagements.

• Universitaetsklinikum Hamburg-Eppendorf (UKE) - Germany


• Aarhus Universitet (AU) - Denmark


• Karolinska Institutet (KI) - Sweden


• ACADEMISCH ZIEKENHUIS GRONINGEN (UMCG) - Netherlands


• Centre Hospitalier Universitaire de Nice (CHUNICE) - France


• Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncológicas Carlos III (FPS-CNIO) - Spain


• LungenClinic Grosshansdorf GMBH (LUNGEN-CG) - Germany


• ILLUMINA CAMBRIDGE LIMITED (ILLUMINA) - United Kingdom


• Horizon Discovery Limited (HDL) - United Kingdom


• LGC Clinical Diagnostics INC (LGC) - United States


• The Synergist (SYNERGIST) - Belgium


• Digestive Cancers Europe DICE (DiCE) - Belgium


• AMGEN (EUROPE) GMBH (UIB) - Switzerland


• Bristol-Myers Squibb Company Corp (BMS) - United States


• F. HOFFMANN-LA ROCHE AG (ROCHE) - Switzerland


• Innovation Acta (INN-ACTA) - Italy


• AstraZeneca UK Limited (AZ) - United Kingdom


• MEDIZINISCHE UNIVERSITAT GRAZ (MUG) - Austria


• Synergist Services (SYNERSERV) - Belgium


• Asociatia Centrul Pentru Inovatie in Medicina (INOMED) - Romania


• CENTRE HOSPITALIER UNIVERSITAIRE MONTPELLIER (CHUM) - France


• AARHUS UNIVERSITETSHOSPITAL(AUH) - Denmark


• Region Stockholm (KH) - Sweden


• Lung Cancer Europe LUCE (LuCE) - Switzerland